McKesson signs deal to buy 70% of Core Ventures (FCS) for ~$2.49B cash

MCKESSON CORP

Purchase price approx. $2.49B in cash for ~70% controlling equity interest in Core Ventures (FCS's admin services org).
Florida Cancer Specialists (250+ physicians, 280+ APPs, ~100 FL locations) to join McKesson's The US Oncology Network.
Transaction subject to regulatory approvals and customary closing conditions; results reported in US Pharmaceutical segment.
McKesson CEO Brian Tyler states deal expands community oncology platform, improves patient outcomes and reduces cost of care.
FCS physicians retain minority interest in Core Ventures and remain independently owned.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.